Ubiquitin-specific protease 14 modulates degradation of cellular prion protein

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Homma, Takujiro ^a   Ishibashi, Daisuke ^a   Nakagaki, Takehiro ^a   Fuse, Takayuki ^a   Mori, Tsuyoshi ^a   Satoh, Katsuya ^a   Atarashi, Ryuichiro ^a   Nishida, Noriyuki ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1-(1-(4-FLUOROPHENYL)-2,5-DIMETHYLPYRROL-3-YL)-2-PYRROLIDIN-1-YLETHANONE; PRION; PRION PROTEIN; PYRROLE DERIVATIVE; PYRROLIDINE DERIVATIVE; UBIQUITIN THIOLESTERASE; USP14 PROTEIN, MOUSE;

ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; PRION; PROTEIN DEGRADATION;

ANIMALS; CELL LINE; GENE EXPRESSION; MICE; PRIONS; PROTEOLYSIS; PRPC PROTEINS; PRPSC PROTEINS; PYRROLES; PYRROLIDINES; UBIQUITIN THIOLESTERASE;

EID: 84931263257     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11028     Document Type: Article

References (41)

1. Prusiner, S. B. Prions. Proc Natl Acad Sci USA 95, 13363-13383 (1998).
2. Stahl, N., Borchelt, D. R., Hsiao, K. & Prusiner, S. B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240 (1987).
3. Turk, E., Teplow, D. B., Hood, L. E. & Prusiner, S. B. Purifcation and properties of the cellular and scrapie hamster prion proteins. European journal of biochemistry/FEBS 176, 21-30 (1988).
4. Haraguchi, T. et al. Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274, 1-13 (1989).
5. Shao, J. et al. Ubiquitin ligase gp78 targets unglycosylated prion protein PrP for ubiquitylation and degradation. PLoS One 9, e92290, doi:10.1371/journal.pone.0092290 (2014).
6. Ma, J. & Lindquist, S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 98, 14955-14960, doi:10.1073/pnas.011578098 (2001).
7. Yedidia, Y., Horonchik, L., Tzaban, S., Yanai, A. & Taraboulos, A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. Embo J 20, 5383-5391, doi:10.1093/emboj/20.19.5383 (2001).
8. Zanusso, G. et al. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem 274, 23396-23404 (1999).
9. Jin, T. et al. Te chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem 275, 38699-38704, doi:10.1074/jbc.M005543200 (2000).
10. Mishra, R. S., Bose, S., Gu, Y., Li, R. & Singh, N. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders. J Alzheimers Dis 5, 15-23 (2003).
11. Borodovsky, A. et al. A novel active site-directed probe specifc for deubiquitylating enzymes reveals proteasome association of USP14. Embo J 20, 5187-5196, doi:10.1093/emboj/20.18.5187 (2001).
12. Hu, M. et al. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. Embo J 24, 3747-3756, doi:10.1038/sj.emboj.7600832 (2005).
13. Peth, A., Besche, H. C. & Goldberg, A. L. Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol Cell 36, 794-804, doi:10.1016/j.molcel.2009.11.015 (2009).
14. Lee, M. J., Lee, B. H., Hanna, J., King, R. W. & Finley, D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol Cell Proteomics 10, R110 003871, doi:10.1074/mcp.R110.003871 (2011).
15. Anderson, C. et al. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J Neurochem 95, 724-731, doi:10.1111/j.1471-4159.2005.03409.x (2005).
16. Leggett, D. S. et al. Multiple associated proteins regulate proteasome structure and function. Mol Cell 10, 495-507 (2002).
17. Chernova, T. A. et al. Pleiotropic efects of Ubp6 loss on drug sensitivities and yeast prion are due to depletion of the free ubiquitin pool. J Biol Chem 278, 52102-52115, doi:10.1074/jbc.M310283200 (2003).
18. Chen, P. C. et al. Te proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J Neurosci 29, 10909-10919, doi:10.1523/JNEUROSCI.2635-09.2009 (2009).
19. Nagai, A. et al. USP14 inhibits ER-associated degradation via interaction with IRE1alpha. Biochem Biophys Res Commun 379, 995-1000, doi:10.1016/j.bbrc.2008.12.182 (2009).
20. Hosokawa, N. et al. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep 2, 415-422, doi:10.1093/embo-reports/kve084 (2001).
21. Lee, B. H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179-184, doi:10.1038/nature09299 (2010).
22. Yamasaki, T. et al. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP. J Gen Virol 93, 668-680, doi:10.1099/vir.0.037101-0 (2012).
23. Amici, M. et al. Interplay between 20S proteasomes and prion proteins in scrapie disease. J Neurosci Res 88, 191-201, doi:10.1002/jnr.22186 (2010).
24. Kristiansen, M. et al. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26, 175-188, doi:10.1016/j. molcel.2007.04.001 (2007).
25. Deriziotis, P. et al. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. Embo J 30, 3065-3077, doi:10.1038/emboj.2011.224 (2011).
26. Nunziante, M. et al. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafcking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J Biol Chem 286, 33942-33953, doi:10.1074/jbc.M111.272617 (2011).
27. Drisaldi, B. et al. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278, 21732-21743, doi:10.1074/jbc.M213247200 (2003).
28. Fioriti, L. et al. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J Biol Chem 280, 11320-11328, doi:10.1074/jbc.M412441200 (2005).
29. Shyng, S. L., Huber, M. T. & Harris, D. A. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268, 15922-15928 (1993).
30. Walmsley, A. R., Watt, N. T., Taylor, D. R., Perera, W. S. & Hooper, N. M. alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafs. Mol Cell Neurosci 40, 242-248, doi:10.1016/j. mcn.2008.10.012 (2009).
31. Hachiya, N., Komata, Y., Harguem, S., Nishijima, K. & Kaneko, K. Possible involvement of calpain-like activity in normal processing of cellular prion protein. Neurosci Lett 490, 150-155, doi:10.1016/j.neulet.2010.12.046 (2011).
32. Chen, S. G. et al. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270, 19173-19180 (1995).
33. Jimenez-Huete, A. et al. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153, 1561-1572, doi:10.1016/S0002-9440(10)65744-6 (1998).
34. McMahon, H. E. et al. Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem 276, 2286-2291, doi:10.1074/jbc.M007243200 (2001).
35. Ma, J. & Lindquist, S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298, 1785-1788, doi:10.1126/science.1073619 (2002).
36. Nishida, N. et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 74, 320-325 (2000).
37. Ishibashi, D. et al. Protective role of interferon regulatory factor 3-mediated signaling against prion infection. J Vi r ol 86, 4947-4955, doi:10.1128/JVI.06326-11 (2012).
38. Homma, T. et al. Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3. Sci Rep 4, 6006, doi:10.1038/srep06006 (2014).
39. Ishibashi, D. et al. Antigenic mimicry-mediated anti-prion efects induced by bacterial enzyme succinylarginine dihydrolase in mice. Vaccine 29, 9321-9328, doi:10.1016/j.vaccine.2011.10.017 (2011).
40. Atarashi, R., Sim, V. L., Nishida, N., Caughey, B. & Katamine, S. Prion strain-dependent diferences in conversion of mutant prion proteins in cell culture. J Virol 80, 7854-7862, doi:10.1128/JVI.00424-06 (2006).
41. Homma, T. et al. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein. Sci Rep 4, 4504, doi:10.1038/srep04504 (2014).